IL1B and autoimmune polyendocrinopathy: In a clinical study of OA subjects treated with a single injection of APS, characterization analysis showed 85.7 % of subject’s APS had an IL-1ra:IL-1 ratio greater than 1000 or a WBC count greater than 30 k/μL.